186 related articles for article (PubMed ID: 16098701)
1. Challenges and opportunities for enhancing biotechnology and technology transfer in developing countries.
Salicrup LA; Fedorková L
Biotechnol Adv; 2006; 24(1):69-79. PubMed ID: 16098701
[TBL] [Abstract][Full Text] [Related]
2. Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies.
Ma JK; Christou P; Chikwamba R; Haydon H; Paul M; Ferrer MP; Ramalingam S; Rech E; Rybicki E; Wigdorovitz A; Yang DC; Thangaraj H
Plant Biotechnol J; 2013 Dec; 11(9):1029-33. PubMed ID: 24119183
[TBL] [Abstract][Full Text] [Related]
3. How can developing countries harness biotechnology to improve health?
Daar AS; Berndtson K; Persad DL; Singer PA
BMC Public Health; 2007 Dec; 7():346. PubMed ID: 18053180
[TBL] [Abstract][Full Text] [Related]
4. Unlocking Marine Biotechnology in the Developing World.
Thompson CC; Kruger RH; Thompson FL
Trends Biotechnol; 2017 Dec; 35(12):1119-1121. PubMed ID: 28890138
[TBL] [Abstract][Full Text] [Related]
5. Applying genomics-related technologies for Africa's health needs.
Singer PA; Court EB; Bhatt A; Frew SE; Greenwood H; Persad DL; Salamanca-Buentello F; Séguin B; Taylor AD; Daer HT; Daar AS
Afr J Med Med Sci; 2007; 36 Suppl():7-14. PubMed ID: 17703557
[TBL] [Abstract][Full Text] [Related]
6. Health related biotechnology transfer in Africa: a critique from a capabilities approach.
Botbol-Baum M
Afr J Med Med Sci; 2007; 36 Suppl():49-54. PubMed ID: 17703565
[TBL] [Abstract][Full Text] [Related]
7. Biotechnology and bioeconomy in China.
Li Q; Zhao Q; Hu Y; Wang H
Biotechnol J; 2006 Nov; 1(11):1205-14. PubMed ID: 17109491
[TBL] [Abstract][Full Text] [Related]
8. Health innovation networks to help developing countries address neglected diseases.
Morel CM; Acharya T; Broun D; Dangi A; Elias C; Ganguly NK; Gardner CA; Gupta RK; Haycock J; Heher AD; Hotez PJ; Kettler HE; Keusch GT; Krattiger AF; Kreutz FT; Lall S; Lee K; Mahoney R; Martinez-Palomo A; Mashelkar RA; Matlin SA; Mzimba M; Oehler J; Ridley RG; Senanayake P; Singer P; Yun M
Science; 2005 Jul; 309(5733):401-4. PubMed ID: 16020723
[TBL] [Abstract][Full Text] [Related]
9. A survey of South-North health biotech collaboration.
Melon CC; Ray M; Chakkalackal S; Li M; Cooper JE; Chadder J; Ke W; Li L; Madkour MA; Aly S; Adly N; Chaturvedi S; Konde V; Daar AS; Singer PA; Thorsteinsdóttir H
Nat Biotechnol; 2009 Mar; 27(3):229-32. PubMed ID: 19270665
[No Abstract] [Full Text] [Related]
10. Licensing IP to ensure accessibility to vaccines and other immunisation-related products.
Mehta JM
Vaccine; 2001 Feb; 19(13-14):1581-7; discussion 1592-3. PubMed ID: 11166878
[No Abstract] [Full Text] [Related]
11. Global health equity in United Kingdom university research: a landscape of current policies and practices.
Gotham D; Meldrum J; Nageshwaran V; Counts C; Kumari N; Martin M; Beattie B; Post N
Health Res Policy Syst; 2016 Oct; 14(1):76. PubMed ID: 27724907
[TBL] [Abstract][Full Text] [Related]
12. BioAsia Licensing and Deal-Making Summit-SRI Conference. Life science partnering and investment on the Pacific Rim 2-3 August, 2004, Coronado, CA, USA.
Xu J
IDrugs; 2004 Sep; 7(9):841-5. PubMed ID: 15470601
[TBL] [Abstract][Full Text] [Related]
13. Value creation and sharing among universities, biotechnology and pharma.
Edwards MG; Murray F; Yu R
Nat Biotechnol; 2003 Jun; 21(6):618-24. PubMed ID: 12776145
[No Abstract] [Full Text] [Related]
14. Development of health biotechnology in developing countries: can private-sector players be the prime movers?
Abuduxike G; Aljunid SM
Biotechnol Adv; 2012; 30(6):1589-601. PubMed ID: 22617902
[TBL] [Abstract][Full Text] [Related]
15. Legal issues in sharing the benefits of biodiversity prospecting.
Mays TD; Mazan KD
J Ethnopharmacol; 1996 Apr; 51(1-3):93-102; discussion 102-9. PubMed ID: 9213633
[TBL] [Abstract][Full Text] [Related]
16. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
Mitropoulos K; Cooper DN; Mitropoulou C; Agathos S; Reichardt JKV; Al-Maskari F; Chantratita W; Wonkam A; Dandara C; Katsila T; Lopez-Correa C; Ali BR; Patrinos GP
OMICS; 2017 Nov; 21(11):647-657. PubMed ID: 29140767
[TBL] [Abstract][Full Text] [Related]
17. Technology licensing: lessons from the US experience.
Sobolski GK; Barton JH; Emanuel EJ
JAMA; 2005 Dec; 294(24):3137-40. PubMed ID: 16380596
[No Abstract] [Full Text] [Related]
18. Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012.
Pagliusi S; Makhoana M; Datla M; Leite L; Hendriks J; Gholami A; Huang W; Gao Y; Jadhav S; Harshavardhan GV; Wu Y; Suhardono M; Homma A
Vaccine; 2013 Jun; 31(31):3111-5. PubMed ID: 23684836
[TBL] [Abstract][Full Text] [Related]
19. NIH licensing performance under par.
Garber K
Nat Biotechnol; 2004 Dec; 22(12):1607-8. PubMed ID: 15605428
[No Abstract] [Full Text] [Related]
20. Biotechnology to improve health in developing countries -- a review.
Acharya T; Kennedy R; Daar AS; Singer PA
Mem Inst Oswaldo Cruz; 2004 Jun; 99(4):341-50. PubMed ID: 15322621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
